Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis

Alexandru Schiopu; J. Bengtsson; Ingrid Söderberg; Sabina Janciauskiene; S. Lindgren; Mikko Ares; P.K. Shah; R. Carlsson; Jan Nilsson; Gunilla Nordin Fredrikson

doi:10.1016/S1567-5688(04)90180-3

Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis

Alexandru Schiopu, J. Bengtsson, Ingrid Söderberg, Sabina Janciauskiene, S. Lindgren, Mikko Ares, P.K. Shah, R. Carlsson, Jan Nilsson, Gunilla Nordin Fredrikson

Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review

159 Citeringar (SciVal)

Originalspråk	engelska
Sidor (från-till)	42
Tidskrift	Atherosclerosis Supplements
Volym	5
Utgåva	1
DOI	https://doi.org/10.1016/S1567-5688(04)90180-3
Status	Published - 2004
Evenemang	74th EAS Congress - Seville, Spanien Varaktighet: 2004 apr. 17 → 2004 apr. 20

Bibliografisk information

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Experimental Cardiovascular Research Unit (013242110), Emergency medicine/Medicine/Surgery (013240200)

Ämnesklassifikation (UKÄ)

Kardiologi

Tillgång till dokument

10.1016/S1567-5688(04)90180-3

Citera det här

@article{25f64ce009644190a69904f4c5fb37ca,

title = "Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis",

author = "Alexandru Schiopu and J. Bengtsson and Ingrid S{\"o}derberg and Sabina Janciauskiene and S. Lindgren and Mikko Ares and P.K. Shah and R. Carlsson and Jan Nilsson and {Nordin Fredrikson}, Gunilla",

note = "The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Experimental Cardiovascular Research Unit (013242110), Emergency medicine/Medicine/Surgery (013240200); 74th EAS Congress ; Conference date: 17-04-2004 Through 20-04-2004",

year = "2004",

doi = "10.1016/S1567-5688(04)90180-3",

language = "English",

volume = "5",

pages = "42",

journal = "Atherosclerosis Supplements",

issn = "1567-5688",

publisher = "Elsevier",

number = "1",

}

Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis. / Schiopu, Alexandru; Bengtsson, J.; Söderberg, Ingrid; Janciauskiene, Sabina; Lindgren, S.; Ares, Mikko; Shah, P.K.; Carlsson, R.; Nilsson, Jan; Nordin Fredrikson, Gunilla.

I: Atherosclerosis Supplements, Vol. 5, Nr. 1, 2004, s. 42.

Forskningsoutput: Tidskriftsbidrag › Publicerat konferensabstract › Peer review

TY - JOUR

T1 - Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis

AU - Schiopu, Alexandru

AU - Bengtsson, J.

AU - Söderberg, Ingrid

AU - Janciauskiene, Sabina

AU - Lindgren, S.

AU - Ares, Mikko

AU - Shah, P.K.

AU - Carlsson, R.

AU - Nilsson, Jan

AU - Nordin Fredrikson, Gunilla

N1 - The information about affiliations in this record was updated in December 2015. The record was previously connected to the following departments: Experimental Cardiovascular Research Unit (013242110), Emergency medicine/Medicine/Surgery (013240200)

PY - 2004

Y1 - 2004

U2 - 10.1016/S1567-5688(04)90180-3

DO - 10.1016/S1567-5688(04)90180-3

M3 - Published meeting abstract

VL - 5

SP - 42

JO - Atherosclerosis Supplements

JF - Atherosclerosis Supplements

SN - 1567-5688

IS - 1

T2 - 74th EAS Congress

Y2 - 17 April 2004 through 20 April 2004

ER -